Utilization of hepatitis C virus infected donors in heart transplant recipients with elevated MELD-XI score.

High-Risk Pulmonary Hypertension Does Not Worsen Outcomes in Heart Transplantation.

Pharmacotherapy of refractory pulmonary arterial hypertension.

Use of Donor Hearts ≥50 Years Old for Septuagenarians in Heart Transplantation.

Evolution of concomitant use of veno-arterial extracorporeal membrane oxygenation support with Impella in cardiogenic shock: From percutaneous femoral Impella to axillary Impella 5.5.

Meta-analysis Comparing the Efficacy of Dobutamine Versus Milrinone in Acute Decompensated Heart Failure and Cardiogenic Shock.

A Comparison of COVID-19 and Influenza-Associated Myocarditis: A Nationwide Study in the United States.

Simple technique of distal leg perfusion during heart transplant in patients with preoperative veno-arterial extracorporeal membrane oxygenation support.

COVID-19, Heart Failure Hospitalizations, and Outcomes: A Nationwide Analysis.

Vericiguat: A Novel Soluble Guanylate Cyclase Stimulator for Use in Patients With Heart Failure.

Cannulation-related adverse events of peripheral veno-arterial extracorporeal membrane oxygenation support in heart transplantation: Axillary versus femoral artery cannulation.

Ex Vivo Heart Perfusion for Cardiac Transplantation Allowing for Prolonged Perfusion Time and Extension of Distance Traveled for Procurement of Donor Hearts: An Initial Experience in the United States.

Heart transplantation using manubrium-sparing sternotomy for sternal re-entry.

Heart recovery from a brain-dead donor with a history of Ravitch procedure for repair of pectus excavatum.

Impact of age on the utility of CardioMEMS device in reducing heart failure readmissions.